	Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study. Drug Des Devel Ther Zhou J, Wang Y, Wen K, Huang C, Huang D, Qin T, Li M, Su Y, Sun Y, Chen P. PMID: 42703567 [PubMed - indexed for MEDLINE]
	Nanomedicine-Empowered CAR-T Therapy for Multiple Myeloma: Toward Programmable, Durable, and Precision Immunotherapy. Int J Nanomedicine Huang C, Zhang X, Teng Y, Zhang Z, Wang B, Gu P, Deng X, Wang D, Xiao H, Zou L, Zhao M, Zheng C, Zeng G, Li J, Huang Z. PMID: 42703556 [PubMed - indexed for MEDLINE]
	Bronchial Artery Chemoembolization (BACE) Combined with PD-1 Blockade Versus Chemotherapy Combined with PD-1 Blockade for Non-Small Cell Lung Cancer in Older Adults. Clin Interv Aging Xiang J, Tu J, Gong W, Chen P, Wang Y, Li W, Zhong J, Ji J, Huang J. PMID: 42703541 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma at a Center of Clinical Excellence in Colombia: A Real-World Cohort Study of Clinical Characteristics, Treatment Trajectories, and Survival. J Hepatocell Carcinoma Torres-Vélez C, Sanabria-Jiménez A, Amaya-Nieto J, Ariza-De La Hoz M, Beltrán-Galvis O, Varón-Puerta A. PMID: 42703529 [PubMed]
	Chlorogenic Acid in Antitumor Therapy: Multi-Pathway Mechanisms, Nanocarrier-Mediated Smart Delivery, and Synergistic Combinatorial Strategies. Int J Nanomedicine Duan H, He J, Wang R, Wu J, Ding H. PMID: 42703520 [PubMed - indexed for MEDLINE]
	Prediction of histological response by PET-CT after 2 weeks of neoadjuvant chemo-radiotherapy for rectal cancer: a prospective clinical trial. J Gastrointest Oncol Reinhorn D, Kundel Y, Gordon N, Prus J, Morgenstern S, Wasserberg N, Groshar D, Bernstine H, Brenner B. PMID: 42703514 [PubMed]
	Metabolic burden but not metabolic dysfunction-associated steatotic liver disease affects the prognosis of patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study. J Gastrointest Oncol Zhang M, Qiu ZC, Dai JL, Wen TF, Li C. PMID: 42703506 [PubMed]
	De-escalated total neoadjuvant therapy for the non-operative management of rectal cancer: Results of the NOM-3/TNT prospective cohort study. Clin Transl Radiat Oncol Skrzypiec B, Paciorek K, Pietrzak L, , Kaminski MF, Wro, Ho, Kapa, Ta, Olesi, Bujko K. PMID: 42703503 [PubMed]
	Lung Cancer Screening-Eligible Population From 2000 to 2050 in Argentina: A Simulation Study Brief Report. JTO Clin Res Rep Salgado MV, Jeon J, Cao P, Boyeras I, Mejia R, Meza R. PMID: 42703497 [PubMed]
	Organ-specific response to atezolizumab + bevacizumab combination therapy for unresectable hepatocellular carcinoma with extrahepatic metastases: a retrospective cohort study. J Gastrointest Oncol Dejima A, Arai K, Chiba T, Kido H, Takata N, Terashima T, Yamashita T, Yamashita T. PMID: 42703494 [PubMed]
	Trajectory identification of high-risk subgroups after colorectal cancer surgery in patients with minimal residual disease: a single-center longitudinal study. J Gastrointest Oncol Zhang Y, Liang L, Zhou R, Wu S, Zhou Y, Luo J, Zeng Y, Xu N, Wen Z. PMID: 42703488 [PubMed]
	Relationships among slow diffusion coefficient and diffusion-derived 'vessel density' signal features, Gadoxetate delayed enhancement, tumor size, tumor grading, and patient survival: an exploratory study of mass-forming intrahepatic cholangiocarcinoma. J Gastrointest Oncol Zheng CJ, Xu FY, Duan XH, Zeng WT, Sun MH, Shen J, Wáng YXJ. PMID: 42703486 [PubMed]
	Global, regional, and national burden of colorectal cancer attributable to modifiable risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. J Gastrointest Oncol Yu M, Lu YP. PMID: 42703476 [PubMed]
	Development of a postoperative risk scoring tool for elderly patients with early gastric cancer: an exploratory prognostic score derivation study. J Gastrointest Oncol Yoo J, Chung B, Kim J, Jeong SA, Min SH, Gong CS, Lee IS, Kim BS, Yoo MW, Yook JH, Kim S, Ko CS. PMID: 42703472 [PubMed]
	Prognostic impact of mucinous adenocarcinoma after curative surgery for stage I-III colorectal cancer: a large population-based cohort study. J Gastrointest Oncol Li J, Zeng T, Xie X, Li D, Yan K, Zhu H. PMID: 42703468 [PubMed]
	Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial. J Gastrointest Oncol Kou F, Wang X, Li J, Wang Z, Xu T. PMID: 42703466 [PubMed]
	Association of ctDNA RAS mutational status and clinical benefits in first-line metastatic colorectal cancer therapy with chemotherapy plus anti-EGFR (overall response rate and progression-free survival): a brief report of systematic review and meta-analysis. J Gastrointest Oncol Valladares-Ayerbes M, García Alfonso P, Heinemann V, Manca P, Stintzing S, Pietrantonio F, Montagut C, Safont Aguilera MJ, Maurel J, González Flores E, Vidal J, Formica V, Sabaté-Pina M, Alfonso-González V, Prat-Llorens G. PMID: 42703453 [PubMed]
	Development and validation of a novel nomogram for predicting long-term survival in gallbladder cancer: a large population-based study using the SEER database. J Gastrointest Oncol Song H, Li ZB, Tai QW, Lyu J. PMID: 42703444 [PubMed]
	Assessing the Accuracy of the Association of Coloproctology of Great Britain and Ireland's Risk Assessment Tool for Polyp Cancer Management: A Retrospective Study. Cureus Akram F, Maryosh S, Kiwan O, Siddique K. PMID: 42703441 [PubMed]
	A study on screening of postoperative chemotherapy beneficial populations in stage II colorectal cancer based on diffusion weighted imaging and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography. J Gastrointest Oncol Wang X, Li L, Wang L, Chen W. PMID: 42703440 [PubMed]

Articles 1 - 20 / 1970277

Page 1 of 98514



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy